-
Mashup Score: 18Prehabilitation for Patients with Cancer Undergoing Radiation Therapy: a Scoping Review - 17 day(s) ago
Prehabilitation is a process of identifying and assessing factors that could compromise the physical and psychological health of patients undergoing cancer treatment and implementing an intervention to combat such concerns. The use of prehabilitation in cancer surgery has yielded positive outcomes in rectal, lung and abdominal cancers. Prehabilitation strategies have potential to improve the management of patients receiving radiation therapy or chemoradiation. The aim of the present study was to map the evidence of the assessment and evaluation of prehabilitation for radiation therapy patients.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0
The PCAR study aimed to assess the efficacy and safety of preoperative transcatheter rectal arterial chemoembolisation (TRACE) in patients with locally advanced rectal cancer (LARC).
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The PCAR study aimed to assess the efficacy and safety of preoperative transcatheter rectal arterial chemoembolisation (TRACE) in patients with locally advanced rectal cancer (LARC).
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Pharyngeal Constrictor Dose–Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy - 3 month(s) ago
Head and neck radiotherapy long-term survival continues to improve and the management of long-term side-effects is moving to the forefront of patient care. Dysphagia is associated with dose to the pharyngeal constrictors and can be measured using patient-reported outcomes to evaluate its effect on quality of life. The aim of the present study was to relate pharyngeal constrictor dose–volume parameters with patient-reported outcomes to identify prognostic dose constraints.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet-
The March Editor's Choice article from Clinical Oncology is out now. Check out "Pharyngeal Constrictor Dose–Volume Histogram Metrics and Patient-reported Dysphagia in Head and Neck Radiotherapy" for some of the most exciting work in oncology. Read it here https://t.co/YFw2j0bbSl https://t.co/iBVyZ5yZEV
-
-
Mashup Score: 0
Cardiac disease is a dose-limiting toxicity in non-small cell lung cancer radiotherapy. The dose to the heart base has been associated with poor survival in multiple institutional and clinical trial datasets using unsupervised, voxel-based analysis. Validation has not been undertaken in a cohort with individual patient delineations of the cardiac base or for the endpoint of cardiac events. The purpose of this study was to assess the association of heart base radiation dose with overall survival and the risk of cardiac events with individual heart base contours.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome - 4 month(s) ago
To present the preliminary results on the clinical utilisation of an online daily adaptive magnetic resonance-guided radiation therapy (MRgRT) for various gynaecological cancers.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
After primary radiotherapy, biochemical recurrence is defined according to the Phoenix criteria as a prostate-specific antigen (PSA) value >2 ng/ml relative to the nadir. Several studies have shown that prostate-specific membrane antigen (PSMA)-ligand positron emission tomography/computed tomography (PET/CT) can help in detecting recurrence in patients with low PSA values. This study aimed to assess the detection rate and patterns of PSMA-ligand PET/CT uptake in patients with suspected biochemical recurrence after primary radiotherapy and with PSA levels below the Phoenix threshold.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
We aimed to build radiomic models for classifying non-small cell lung cancer (NSCLC) histopathological subtypes through a dual-centre dataset and comprehensively evaluate the effect of ComBat harmonisation on the performance of single- and multimodality radiomic models.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The phase 3 FAST-Forward trial reported outcomes for 26 and 27 Gy schedules delivered in 5 fractions over 1 week versus 40 Gy in 15 fractions over 3 weeks in 4000 patients. We discuss concerns raised by the radiotherapy community in relation to implementing this schedule.
Source: www.clinicaloncologyonline.netCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0Table of Contents page: Clinical Oncology - 2 year(s) ago
EditorialOncoFlash – Research Updates in a Flash! (May edition)C. Crockett,C. LorimerPublished online: March 26, 2022p275-276Full-Text HTMLPDF When Less is More: The Rising Tide of HypofractionationK. Aitken,S. MukherjeePublished online: March 16, 2022p277-279Full-Text HTMLPDF Full length articleHow Low Can You Go? The Radiobiology of HypofractionationD.H….
Source: www.clinicaloncologyonline.netCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
A helpful scoping review on #prehab in #radonc from @lauremarignol Heterogeneity (diseases, interventions and outcome assessments) a problem in the evidence but enough signal in the noise to keep pushing. Free full text https://t.co/hlInvJXWdL https://t.co/XvihAaRkLq